Beijing Hotgen Biotech Co Ltd Cash Flow Reinvestment Rate
Beijing Hotgen Biotech Co Ltd cash flow reinvestment rate. Beijing Hotgen Biotech Co Ltd (688068) has a Cash Flow Reinvestment Rate of 4.82x as of September 2025, reinvesting CN¥14.73 Million (capex CN¥14.73 Million ) from operating cash flow of CN¥3.05 Million. Explore 688068 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Beijing Hotgen Biotech Co Ltd (2016–2022)
Cash flow reinvestment rate of Beijing Hotgen Biotech Co Ltd from 2016 to 2022. Historical reinvestment intensity for Beijing Hotgen Biotech Co Ltd across 7 annual periods. Explore capital reinvestment ratio of Beijing Hotgen Biotech Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Beijing Hotgen Biotech Co Ltd Cash Flow Reinvestment Rate by Year (2016–2022)
Beijing Hotgen Biotech Co Ltd cash flow reinvestment rate by year from 2016 to 2022. Year-by-year capital reinvestment analysis for Beijing Hotgen Biotech Co Ltd. For the full cash flow conversion analysis, see Beijing Hotgen Biotech Co Ltd (688068) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.73x | CN¥1.70 Billion | CN¥978.75 Million | CN¥565.21 Million | ▲ +159.5% |
| 2021 | 0.67x | CN¥1.77 Billion | CN¥2.64 Billion | CN¥398.86 Million | ▼ -92.9% |
| 2020 | 9.35x | CN¥1.54 Billion | CN¥164.62 Million | CN¥172.27 Million | ▼ -87.6% |
| 2019 | 75.11x | CN¥1.45 Billion | CN¥19.37 Million | CN¥88.48 Million | ▲ +193.5% |
| 2018 | 25.59x | CN¥1.41 Billion | CN¥55.04 Million | CN¥42.00 Million | ▲ +330.0% |
| 2017 | 5.95x | CN¥136.61 Million | CN¥22.95 Million | CN¥69.05 Million | ▲ +546.2% |
| 2016 | 0.92x | CN¥41.95 Million | CN¥45.54 Million | CN¥21.18 Million | — |